Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-26
1996-10-15
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 514221, 540493, 540495, 540504, 540512, A61K 3155
Patent
active
055654495
ABSTRACT:
A benzodiazepinedione derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
REFERENCES:
patent: 5403836 (1995-04-01), Blackburn et al.
Barker Peter
Blackburn Brent
Gadek Thomas
McDowell Robert
McGee Lawrence
Bond Robert T.
Genentech Inc.
Winter Daryl B.
LandOfFree
Nonpeptidyl integrin inhibitors having specificity for the GPII. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonpeptidyl integrin inhibitors having specificity for the GPII., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonpeptidyl integrin inhibitors having specificity for the GPII. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246277